The latest price target for ProMIS Neurosciences (NASDAQ:PMN) was reported by Guggenheim on April 1, 2025. The analyst firm set a price target for $6.00 expecting PMN to rise to within 12 months (a possible 769.57% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for ProMIS Neurosciences (NASDAQ:PMN) was provided by Guggenheim, and ProMIS Neurosciences reiterated their buy rating.

There is no last upgrade for ProMIS Neurosciences

There is no last downgrade for ProMIS Neurosciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProMIS Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProMIS Neurosciences was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.

While ratings are subjective and will change, the latest ProMIS Neurosciences (PMN) rating was a reiterated with a price target of $6.00 to $6.00. The current price ProMIS Neurosciences (PMN) is trading at is $0.69, which is out of the analyst’s predicted range.